Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)A Pharmacodynamic and Safety Study of BCS in Healthy Volunteers
- First Posted Date
- 2015-11-03
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- Lustre Pharmaceutical Lab Co., Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT02594449
- Locations
- 🇨🇳
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD
Phase 4
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Normal saline
- First Posted Date
- 2014-10-21
- Last Posted Date
- 2014-10-21
- Lead Sponsor
- Lustre Pharmaceutical Lab Co., Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT02269800
News
No news found